EPO and breast carcinoma: In preclinical studies, EPO has been shown to induce the proliferation of different cancer cells, such as colorectal (4) or breast cancer (4–7), and may stimulate the conversion of non-stem breast cancer cells into breast cancer-initiating cells (7, 8).